Acceleron Pharma to Participate in Two Healthcare Investor Conferences in February

CAMBRIDGE, Mass.--()--Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic candidates that regulate cellular growth and repair, today announced that senior management will participate in two upcoming healthcare investor conferences.

Conference Details:

         

Event:

LEERINK Partners 5th Annual Global Healthcare Conference

Date / Time:

Wednesday, February 10, 2016 at 1:50 PM EST

Location:

Waldorf Astoria, New York, NY

 

Event:

SunTrust Robinson Humphrey 2016 Orphan Drug Day

Date / Time:

Tuesday, February 23, 2016

Location:

JW Marriot Essex House, New York, NY

 

A live audio webcast of the fireside chat at the LEERINK conference will be available on the “Events and Presentations” page in the Investors & Media section on the Company’s website (www.acceleronpharma.com). A replay of the webcast will also be available from Acceleron’s website.

About Acceleron

Acceleron is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic candidates that regulate cellular growth and repair. The company is a leader in understanding the biology of the Transforming Growth Factor-Beta protein superfamily, a large and diverse group of molecules that are key regulators in the growth and repair of tissues throughout the human body, and in targeting these pathways to develop important new medicines. Acceleron has built a highly productive R&D platform that has generated innovative clinical and preclinical therapeutic candidates with novel mechanisms of action. These therapeutic candidates have the potential to significantly improve clinical outcomes for patients with cancer and rare diseases.

For more information, please visit www.acceleronpharma.com.

Contacts

Acceleron Pharma Inc.
Todd James, 617-649-9393
Senior Director, Investor Relations and Corporate Communications
or
Media:
BMC Communications LLC
Brad Miles, 646-513-3125

Contacts

Acceleron Pharma Inc.
Todd James, 617-649-9393
Senior Director, Investor Relations and Corporate Communications
or
Media:
BMC Communications LLC
Brad Miles, 646-513-3125